This site is intended for healthcare professionals and relevant decision makers.

THElifeSCIENCE

About Us Contact Us

© 2025 - 2026

The Life Science Feed. All rights reserved.

A digital publication from Grá & Mawi Media Co.

THE life SCIENCE

Cardiology
Dentistry
Endocrinology
General Practice
Haematology
Infectious Diseases
Obstetrics & Gyn
Oncology
Pediatrics
Pulmonology

•

Aortic Valve Stenosis
Breast Neoplasms
Chronic Kidney Disease
Congenital Heart Defects
Coronary Artery Disease
Fatty Liver
Heart Failure
Infertility Female
Myocardial Infarction
Obesity

•

Case
Guidelines
Innovation
Insights
News
Policy
Practice
Research

THE life SCIENCE

Trusted medical news for healthcare professionals

Friday, 1 May 2026

Today on The Life Science Feed

Cardiology Oncology Endocrinology Neurology Nephrology Pulmonology Gastroenterology Rheumatology Hepatology Psychiatry Infectious Diseases Haematology Immunology Dermatology Obstetrics & Gyn Musculoskeletal Pediatrics Geriatrics Rare Diseases General Practice

Disease Area

coronary artery disease

Loading articles...

About Us

About
Editorial Policy
AI Disclaimer
Advertise
Contact Us

OUR PARTNERS:

THE life SCIENCE

Accessibility
Advertising Policy
AI Disclaimer
Community Standards
Cookie Information
Copyright
Modern Slavery Statement
Privacy Policy
Terms & Conditions

© 2025 - 2026 The Life Science Feed. All rights reserved. A digital publication from Grá & Mawi Media Co.

CategoryKeyword

PCSK9 Inhibitors Move Upstream: Evolocumab Tested in Diabetes Without Known Atherosclerosis
VESALIUS-CV tests evolocumab in diabetic patients without established atherosclerosis, while new trials probe plaque biology and lipid pathways beyond LDL.
Read more